We are live on
!
Find out more
WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$4.16B
1-Year Est. Return
30.77%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.93B
AUM Growth
+$1.15B
(+30%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
23.66%
Top 10 Holdings %
Top 10 Hldgs %
15.43%
Holding
758
New
275
Increased
122
Reduced
113
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$106M |
| 2 |
AGN
Allergan plc
AGN
|
+$93.1M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$79.9M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$75.8M |
| 5 |
NNN REIT
NNN
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cousins Properties
CUZ
|
+$87.3M |
| 2 |
VICI Properties
VICI
|
+$58.6M |
| 3 |
Ventas
VTR
|
+$50.3M |
| 4 |
Boston Properties
BXP
|
+$39.8M |
| 5 |
Americold
COLD
|
+$34.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.43% |
| 2 | Technology | 10.03% |
| 3 | Industrials | 7.7% |
| 4 | Healthcare | 6.67% |
| 5 | Energy | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Rigel Pharmaceuticals
RIGL
$708M
| $954K | 0.02% |
51,000
| – | – |
|
452
Gilead Sciences
GILD
$163B
| $951K | 0.02% |
15,000
+7,000
| +88% | +$458K |
|
|
ICPT
453
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $929K | 0.02% |
14,000
+1,000
| +8% | +$67.2K |
|
454
MKS Inc
MKSI
$20.9B
| $923K | 0.02% |
10,000
-25,000
| -71% | -$2.06M |
|
455
Trane Technologies
TT
$106B
| $899K | 0.02% |
7,298
-2,372
| -25% | -$289K |
|
456
AbbVie
ABBV
$457B
| $878K | 0.02% |
11,593
-13,407
| -54% | -$919K |
|
457
CALL
Saic
SAIC
$5.01B
| $874K | 0.02% |
+10,000
| New | +$850K |
|
458
PUT
Abbott
ABT
$183B
| $837K | 0.02% |
+10,000
| New | +$850K |
|
459
Simply Good Foods
SMPL
$940M
| $823K | 0.02% |
28,392
-223,608
| -89% | -$6.24M |
|
460
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.8B
| $796K | 0.02% |
2,257
+788
| +54% | +$276K |
|
|
CXO
461
DELISTED
CONCHO RESOURCES INC.
CXO
| $775K | 0.02% |
+11,415
| New | +$929K |
|
462
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
| $766K | 0.02% |
9,873
-23,627
| -71% | -$1.81M |
|
463
Uber
UBER
$138B
| $762K | 0.02% |
25,000
-512,352
| -95% | -$19.3M |
|
464
PUT
DexCom
DXCM
$28.4B
| $746K | 0.02% |
20,000
| – | – |
|
465
Papa John's
PZZA
$1.02B
| $722K | 0.01% |
13,783
-237,689
| -95% | -$11.2M |
|
466
XPO
XPO
$24.2B
| $716K | 0.01% |
28,914
-118,547
| -80% | -$2.74M |
|
|
MIME
467
DELISTED
Mimecast Limited
MIME
| $713K | 0.01% |
20,000
-5,000
| -20% | -$217K |
|
468
CALL
Red Rock Resorts
RRR
$3.8B
| $705K | 0.01% |
+34,700
| New | +$724K |
|
|
ALBO
469
DELISTED
Albireo Pharma Inc
ALBO
| $700K | 0.01% |
35,000
| – | – |
|
470
Insmed
INSM
$22.8B
| $688K | 0.01% |
39,000
+9,000
| +30% | +$174K |
|
471
Precision BioSciences
DTIL
$190M
| $671K | 0.01% |
+2,667
| New | +$868K |
|
|
EPZM
472
DELISTED
Epizyme, Inc
EPZM
| $670K | 0.01% |
65,000
| – | – |
|
473
Orion
OEC
$372M
| $668K | 0.01% |
+40,000
| New | +$654K |
|
474
Vanda Pharmaceuticals
VNDA
$316M
| $664K | 0.01% |
50,000
-30,000
| -38% | -$418K |
|
475
PUT
Frontline
FRO
$8.61B
| $628K | 0.01% |
69,000
-41,000
| -37% | -$331K |
|
Similar funds
SS
PMEF
CC
GW
BC
GC
WP
BWM
Weiss Multi-Strategy Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, Weiss Multi-Strategy Advisers held 758 positions worth $4.93B, up 30% from $3.78B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Weiss Multi-Strategy Advisers deployed $1.17B of net new capital in Q3 2019, opening 275 new positions and adding to 122 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.
By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was VICI Properties, an estimated $58.6M trimmed.
- Weiss Multi-Strategy Advisers's largest Q3 2019 buy was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.
- Weiss Multi-Strategy Advisers added most to Celgene Corp in Q3 2019, an estimated $106M increase.
- Weiss Multi-Strategy Advisers's biggest Q3 2019 reduction was VICI Properties, cutting an estimated $58.6M.
- Weiss Multi-Strategy Advisers fully exited Cousins Properties in Q3 2019, selling an estimated $87.3M.
- Weiss Multi-Strategy Advisers's ten largest holdings make up 15% of its $4.93B portfolio in Q3 2019.
- Weiss Multi-Strategy Advisers opened 275 new positions and closed 194 in Q3 2019.
- Weiss Multi-Strategy Advisers's portfolio value rose 30% quarter-over-quarter to $4.93B.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.